Research Studies and Clinical Trials

St. Luke’s commitment to providing quality care that promotes healing and return of function is exemplified in the ongoing research studies at St. Luke’s. Following is a list of research projects at St. Luke's that have been approved by a research ethics board and are in-progress. If you would like information about participating in any of these studies, please email us at SLRIresearch@st-lukes.org or call us at (509) 473-6234.


MRI-based Biomarkers for Characterization of Amyotrophic Lateral Sclerosis

Investigators: Bryn Martin, PhD (U of I); Gregory T. Carter, MD; Douglas L. Weeks, PhD; Brian Petersen, MD (Inland Imaging)

 

International,multi-center, randomized, double-blind, placebo-controlled phase III study assessing in parallel groups the efficacy and safety of 2 doses of PXT3003 inpatients with Charcot-Marie-Tooth Disease type 1A treated 15 months (ProtocolCLN-PXT3003-02)

Investigators: Gregory T. Carter, MD; Erik R. Ensrud, MD

 

Using Wearable Motion Sensors to Measure Patient Physical Activity during Rehabilitation

Investigators: Douglas L. Weeks, PhD; Diane Cook, PhD (WSU); Gina Sprint, MS (WSU)


A Survey of Physician, Physician Assistant, and Student Pharmacist Satisfaction with a Student Pharmacist Medication Prior Authorization Need Identification Service

Investigator: Christopher L. Greer, RPh


An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits in Subjects Who Participated inthe DALF-PS-1016 Study (MILESTONE)

Investigators: Gregory T. Carter, MD; Joseph M. Gaines, PA-C


A Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacyand Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets forTreatment of Stable Walking Deficits in Post-Ischemic Stroke (MILESTONE)

Investigators: Gregory T. Carter, MD; Joseph M. Gaines, PA-C


Phone Interview of Patient Satisfaction with Education on Insulin Use and Post-Discharge Insulin Related Problems

Investigator: Christopher L. Greer, RPh


Comparison of Two Psycho-educational Family Group Interventions for Persons with SCI and their Caregivers

Investigators: Douglas L. Weeks, PhD; Dennis G. Dyck, PhD (WSU); Diane Norell, MSW, OTR/L (EWU)

 

Using Wearable Motion Sensors to Measure Rehabilitation Patient Gait Characteristics

Investigators: Diane Cook, PhD (WSU); Gina Sprint, MS (WSU); Vladimir Borisov, MS (WSU); Douglas L. Weeks, PhD

 

The Modified Mini-Mental State Examination as an Indicator of Cognitive Impairment in Traumatic Brain Injury

Investigators: Douglas L. Weeks, PhD; Sara Ambrose, MS, CCC-SLP; Jennifer Lawton, MS, CCC-SLP; Angelique Tindall, PhD, RD

 

Simulated Rehabilitation Environment to Support Home and Community Reintegration

Investigators: Kayela Robertson (WSU); Maureen Schmitter-Edgecombe, PhD (WSU); Douglas L. Weeks, PhD

 

Psychosocial Predictors of Cardiac Rehabilitation Progress

Investigators: Bruce Wright, MD (WSU); Kathleen Caffrey, BS (WSU)

 

A Mental Health Program for Women inCardiovascular Rehabilitation

Investigators: E. Devon Eldridge, MS (WSU); Bruce R. Wright, MD (WSU)


Connect with us: